Inflammatory indices—Systemic Immune-Inflammation Index (SII) and Systemic Inflammatory Response Index (SIRI)—during Pregnancy and Associations with Gestational Diabetes Mellitus
Danwei Zhang,Yating Zeng,Bin Sun,Wei Li,Wenjuan Liu,Haiyan Gao,Yibing Zhu,Haibo Li,Qiang Chen
DOI: https://doi.org/10.2147/jir.s474154
IF: 4.5
2024-09-19
Journal of Inflammation Research
Abstract:Danwei Zhang, 1 Yating Zeng, 1 Bin Sun, 2 Wei Li, 2 Wenjuan Liu, 2 Haiyan Gao, 2 Yibing Zhu, 2 Haibo Li, 2, &ast Qiang Chen 1, &ast 1 Department of Cardiac Surgery, Fujian Children's Hospital (Fujian Branch of Shanghai Children's Medical Center), College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fuzhou, People's Republic of China; 2 Division of Birth Cohort Study, Fujian Maternity and Child Health Hospital, College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fuzhou, People's Republic of China &astThese authors contributed equally to this work Correspondence: Qiang Chen, Department of Cardiac Surgery, Fujian Children's Hospital (Fujian Branch of Shanghai Children's Medical Center), College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, No. 966 Hengyu Road, Jinan District, Fuzhou, 350014, People's Republic of China, Email Haibo Li, Division of Birth Cohort Study, Fujian Maternity and Child Health Hospital, College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, No. 18 Daoshan Road, Gulou District, Fuzhou, 350001, People's Republic of China, Email Purpose: Gestational diabetes mellitus (GDM) is a prevalent complication during pregnancy. This study aimed to explore the associations between inflammatory indices during pregnancy and the development of GDM. Methods: Data from the Fujian Birth Cohort Study between March 2019 and December 2022 were used. Participants who delivered a live-born singleton were included and categorized into GDM and non-GDM groups. Two inflammatory indices, the systemic immune-inflammation index (SII) and systemic inflammatory response index (SIRI), were calculated for each trimester of pregnancy via hematological parameters from complete blood count tests. The distributions of inflammatory indicators across trimesters were compared between the GDM and non-GDM groups. Additionally, multivariable logistic regression models were employed to investigate the associations between inflammatory indices and the incidence of GDM. Results: A total of 17297 participants were included, 21.2% of whom were diagnosed with GDM. In the first trimester, the median SIIs for the GDM and non-GDM groups were 817.7× 10 9 /L and 756.9× 10 9 /L, respectively, whereas the median SIRIs were 1.6× 10 9 /L and 1.5× 10 9 /L, respectively. In both groups, the SII increased to its peak in the second trimester before declining, whereas the SIRI progressively increased throughout pregnancy. The SII and SIRI were greater in the GDM group than in the non-GDM group during the first two trimesters but lower in the third trimester. Nonlinear positive associations between first-trimester SII and SIRI levels and GDM were observed, with extreme quartile odds ratios of 1.32 (95% CI: 1.19, 1.48) and 1.39 (95% CI: 1.24, 1.55), respectively. Conclusion: The SII and SIRI increased and reached their peak values in the second and third trimesters of pregnancy, respectively. Elevated levels of the SII and SIRI in early pregnancy were linked to an increased risk of GDM, suggesting their potential utility as screening tools for GDM. Keywords: gestational diabetes mellitus, GDM, systemic immune-inflammation index, SII, systemic inflammatory response index, SIRI Gestational diabetes mellitus (GDM), defined as hyperglycemia first detected during pregnancy, is the most common pregnancy complication. 1,2 GDM increases the risk of adverse pregnancy outcomes, 3 as well as the long-term risk of cardiometabolic disorders in both mothers and offspring. 2,4,5 Taking proactive measures to prevent and monitor GDM is essential for successful GDM management. Pregnancy is characterized by an altered inflammatory profile compared with the nonpregnant state, and an imbalance between pro- and anti-inflammatory cytokines may cause several pregnancy complications. 6 Emerging evidence suggests that GDM is associated with a chronic inflammatory state. 7,8 Recent advances have introduced two novel systemic inflammatory indices 9,10 — the systemic immune-inflammation index (SII) and the system inflammation response index (SIRI)—derived from complete blood cell counts. These indices are increasingly utilized in disease diagnosis and outcome prediction. 11,12 For instance, studies have shown that elevated SII values are correlated with an increased risk of diabetes and are associated with increased mortality in diabetic patient -Abstract Truncated-
immunology